Winston & Strawn Sponsors the Centri Capital Conference 2025

Winston & Strawn was proud to sponsor the inaugural Centri Capital Conference at Nasdaq in New York City. The event brought together innovative leaders across healthcare, life sciences, and disruptive technologies to explore emerging capital market trends and challenges.

Highlights included engaging company presentations, one-on-one meetings, and forward-thinking discussions on venture capital, private equity, artificial intelligence, cryptocurrency, and global regulatory shifts. Mike Blankenship, Managing Partner of Houston and Co-Chair of Capital Markets, joined David Hochman, Chairman, CEO, and Founder of Orchestra BioMed, for a compelling fireside chat on the biotech outlook and capital strategies for 2025.

Key Takeaways

• Capital Formation: Disruptive companies face evolving challenges on their journey through the capital markets—timing, structure, and market conditions remain key.
• Biotech Outlook: Mike Blankenship and David Hochman offered actionable insights on navigating biotech growth, funding strategies, and regulatory landscapes.
• AI & Markets: Artificial intelligence continues to transform both investor behavior and issuer preparedness.
• Crypto & Blockchain: These technologies are reshaping infrastructure and access in capital markets—regulatory clarity will be critical.
• Global Perspective: Anticipating economic shifts and policy updates is essential for strategic decision-making in 2025 and beyond.